<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01906567</url>
  </required_header>
  <id_info>
    <org_study_id>zekai tahir burak heavy metal</org_study_id>
    <nct_id>NCT01906567</nct_id>
  </id_info>
  <brief_title>İs There a Relationship Between Severity of Preeclampsia and Maternal Heavy Metal Levels?</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zekai Tahir Burak Women's Health Research and Education Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zekai Tahir Burak Women's Health Research and Education Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study, to investigate whether severity of preeclampsia is associated with&#xD;
      altered levels of heavy metals (Cd, Hg, arsenic and Pb) in maternal blood, fetal blood, and&#xD;
      maternal hair.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The unfavorable effects of heavy metals on human health is well known. The main threats to&#xD;
      human health from heavy metals are associated with exposure to lead, cadmium, mercury and&#xD;
      arsenic. They may be toxic at the levels previously thought to have no adverse effect on&#xD;
      human.In utero environmental exposures can have long term consequences to health and&#xD;
      development.İn spite of what is known about the neurotoxicity from exposure to heavy metals,&#xD;
      the health effects from co-exposure to these chemicals and the biologically effective doses&#xD;
      are not known exactly.&#xD;
&#xD;
      Preeclampsia is associated with increased maternal and infant mortality and morbidity. The&#xD;
      exact etiology is not clear. Several evidences indicate that various environmental factors&#xD;
      and elements may play a role in pre-eclampsia.&#xD;
&#xD;
      significant increase in Pb, cadmium (Cd), copper (Cu) and magnesium (Mg) and decrease in zinc&#xD;
      (Zn) in amniotic fluid are associated with preeclampsia. Pb as this metal has well known&#xD;
      adverse effects on renal system and blood pressures Effects of Pb on reproductive system have&#xD;
      been studied intensively, e.g. other pregnancy outcome and pregnancy hypertension.&#xD;
&#xD;
      However, the relationship between the severity of pre-eclampsia and heavy metal levels have&#xD;
      not been investigated.&#xD;
&#xD;
      The purpose of this study, to investigate whether severity of preeclampsia is associated with&#xD;
      altered levels of heavy metals (Cd, Hg, arsenic and Pb) in maternal blood, fetal blood, and&#xD;
      maternal hair.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">September 2013</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>increased levels of heavy metals in preeclamptic women</measure>
    <time_frame>6 months</time_frame>
    <description>mercury, cadmium and lead levels in maternal blood and hair</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Mild Pre-eclampsia</condition>
  <condition>Severe Preeclampsia</condition>
  <arm_group>
    <arm_group_label>severe preeclamptic women</arm_group_label>
    <description>Severe preeclampsia is defined as the presence of 1 of the following symptoms or signs in the presence of preeclampsia:&#xD;
• SBP of 160 mm Hg or higher or DBP of 110 mm Hg or higher on 2 occasions at least 6 hours apart&#xD;
• Proteinuria of more than 5 g in a 24-hour collection or more than 3+ on 2 random urine samples collected at least 4 hours apart&#xD;
• Pulmonary edema or cyanosis&#xD;
• Oliguria (&lt; 400 mL in 24 h)&#xD;
• Persistent headaches&#xD;
• Epigastric pain and/or impaired liver function&#xD;
• Thrombocytopenia&#xD;
• Oligohydramnios, decreased fetal growth, or placental abruption</description>
  </arm_group>
  <arm_group>
    <arm_group_label>mild preeclamptic women</arm_group_label>
    <description>Mild preeclampsia is defined as the presence of hypertension (BP ≥140/90 mm Hg) on 2 occasions, at least 6 hours apart, but without evidence of end-organ damage in the patient.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Pregnant Women</arm_group_label>
    <description>healthy pregnant women at term who not developed any complication of pregnancy</description>
  </arm_group>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      maternal whole blood maternal hair umbilical whole blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        pregnant women with preeclampsia&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Clinical diagnosis of preeclampsia (diagnosed per ACOG criteria)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        known chronic disease multipl pregnancies&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ayse kirbas, md</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zekai Tahir Burak Women's Health Research and Education Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ayse kirbas</last_name>
    <phone>+90 0533 646 9213</phone>
    <email>ayseozdemirkirbas@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>sibel ozler</last_name>
    <phone>+ 90 545 233 1363</phone>
    <email>dr_sibelozler@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zekai Tahir Burak Maternity Teaching Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>6400</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ayse kirbas, md</last_name>
      <phone>+90 0 533 646 92 13</phone>
      <email>ayseozdemirkirbas@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>sibel ozler, md</last_name>
    </contact_backup>
    <investigator>
      <last_name>ayse kirbas, md</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>sibel ozler</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zekai Tahir Burak Education and Research Hospital</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ayse kirbas, md</last_name>
    </contact>
    <investigator>
      <last_name>ayse kirbas, md</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790505/</url>
    <description>Maternal Blood Lead Levels and the Risk of Pregnancy-Induced Hypertension: The EDEN Cohort Study</description>
  </link>
  <link>
    <url>http://ncbi.nlm.nih.gov/</url>
    <description>Environmental lead level and pregnancy-induced hypertension.</description>
  </link>
  <verification_date>July 2013</verification_date>
  <study_first_submitted>July 5, 2013</study_first_submitted>
  <study_first_submitted_qc>July 20, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 24, 2013</study_first_posted>
  <last_update_submitted>August 4, 2013</last_update_submitted>
  <last_update_submitted_qc>August 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 6, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zekai Tahir Burak Women's Health Research and Education Hospital</investigator_affiliation>
    <investigator_full_name>Ayse Kirbas</investigator_full_name>
    <investigator_title>Ayse Kirbas, MD</investigator_title>
  </responsible_party>
  <keyword>cadmium</keyword>
  <keyword>lead</keyword>
  <keyword>mercury</keyword>
  <keyword>preeclampsia</keyword>
  <keyword>pregnancy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Eclampsia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

